Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta

M. Zhao, A. Nanbo, D. Becnel, Z. Qin, GF. Morris, L. Li, Z. Lin

. 2020 ; 94 (22) : . [pub] 20201027

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011983

Grantová podpora
P20 GM121288 NIGMS NIH HHS - United States

E-zdroje Online Plný text

NLK Free Medical Journals od 1967 do Před 6 měsíci
Freely Accessible Science Journals od 1967 do Před 6 měsíci
PubMed Central od 1967 do Před 1 rokem
Europe PubMed Central od 1967 do Před 6 měsíci
Open Access Digital Library od 1967-02-01
Open Access Digital Library od 1967-02-01

The Epstein-Barr virus (EBV) immediate early transactivator Zta plays a key role in regulating the transition from latency to the lytic replication stages of EBV infection. Regulation of Zta is known to be controlled through a number of transcriptional and posttranscriptional events. Here, we show that Zta is targeted for ubiquitin modification and that this can occur in EBV-negative and in EBV-infected cells. Genetic studies show critical roles for both an amino-terminal region of Zta and the basic DNA binding domain of Zta in regulating Zta ubiquitination. Pulse-chase experiments demonstrate that the bulk population of Zta is relatively stable but that at least a subset of ubiquitinated Zta molecules are targeted for degradation in the cell. Mutation of four out of a total of nine lysine residues in Zta largely abrogates its ubiquitination, indicating that these are primary ubiquitination target sites. A Zta mutant carrying mutations at these four lysine residues (lysine 12, lysine 188, lysine 207, and lysine 219) cannot induce latently infected cells to produce and/or release infectious virions. Nevertheless, this mutant can induce early gene expression, suggesting a possible defect at the level of viral replication or later in the lytic cascade. As far as we know, this is the first study that has investigated the targeting of Zta by ubiquitination or its role in Zta function.IMPORTANCE Epstein-Barr virus (EBV) is a ubiquitous human pathogen and associated with various human diseases. EBV undergoes latency and lytic replication stages in its life cycle. The transition into the lytic replication stage, at which virus is produced, is mainly regulated by the viral gene product, Zta. Therefore, the regulation of Zta function becomes a central issue regarding viral biology and pathogenesis. Known modifications of Zta include phosphorylation and sumoylation. Here, we report the role of ubiquitination in regulating Zta function. We found that Zta is subjected to ubiquitination in both EBV-infected and EBV-negative cells. The ubiquitin modification targets 4 lysine residues on Zta, leading to both mono- and polyubiquitination of Zta. Ubiquitination of Zta affects the protein's stability and likely contributes to the progression of viral lytic replication. The function and fate of Zta may be determined by the specific lysine residue being modified.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011983
003      
CZ-PrNML
005      
20210507103355.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1128/JVI.01298-20 $2 doi
035    __
$a (PubMed)32847852
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zhao, Mengmeng $u Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA $u Tulane Cancer Center, New Orleans, Louisiana, USA
245    10
$a Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta / $c M. Zhao, A. Nanbo, D. Becnel, Z. Qin, GF. Morris, L. Li, Z. Lin
520    9_
$a The Epstein-Barr virus (EBV) immediate early transactivator Zta plays a key role in regulating the transition from latency to the lytic replication stages of EBV infection. Regulation of Zta is known to be controlled through a number of transcriptional and posttranscriptional events. Here, we show that Zta is targeted for ubiquitin modification and that this can occur in EBV-negative and in EBV-infected cells. Genetic studies show critical roles for both an amino-terminal region of Zta and the basic DNA binding domain of Zta in regulating Zta ubiquitination. Pulse-chase experiments demonstrate that the bulk population of Zta is relatively stable but that at least a subset of ubiquitinated Zta molecules are targeted for degradation in the cell. Mutation of four out of a total of nine lysine residues in Zta largely abrogates its ubiquitination, indicating that these are primary ubiquitination target sites. A Zta mutant carrying mutations at these four lysine residues (lysine 12, lysine 188, lysine 207, and lysine 219) cannot induce latently infected cells to produce and/or release infectious virions. Nevertheless, this mutant can induce early gene expression, suggesting a possible defect at the level of viral replication or later in the lytic cascade. As far as we know, this is the first study that has investigated the targeting of Zta by ubiquitination or its role in Zta function.IMPORTANCE Epstein-Barr virus (EBV) is a ubiquitous human pathogen and associated with various human diseases. EBV undergoes latency and lytic replication stages in its life cycle. The transition into the lytic replication stage, at which virus is produced, is mainly regulated by the viral gene product, Zta. Therefore, the regulation of Zta function becomes a central issue regarding viral biology and pathogenesis. Known modifications of Zta include phosphorylation and sumoylation. Here, we report the role of ubiquitination in regulating Zta function. We found that Zta is subjected to ubiquitination in both EBV-infected and EBV-negative cells. The ubiquitin modification targets 4 lysine residues on Zta, leading to both mono- and polyubiquitination of Zta. Ubiquitination of Zta affects the protein's stability and likely contributes to the progression of viral lytic replication. The function and fate of Zta may be determined by the specific lysine residue being modified.
650    _2
$a buněčné linie $7 D002460
650    _2
$a infekce virem Epsteina-Barrové $x virologie $7 D020031
650    _2
$a regulace exprese virových genů $7 D015967
650    _2
$a virus Epsteinův-Barrové $x genetika $x fyziologie $7 D004854
650    _2
$a lidé $7 D006801
650    _2
$a mutace $7 D009154
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a vazba proteinů $7 D011485
650    _2
$a proteinové domény $7 D000072417
650    _2
$a trans-aktivátory $x genetika $x metabolismus $7 D015534
650    _2
$a ubikvitin $x metabolismus $7 D025801
650    _2
$a virové proteiny $x genetika $x metabolismus $7 D014764
650    _2
$a replikace viru $7 D014779
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nanbo, Asuka $u National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki, Japan
700    1_
$a Becnel, David $u Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
700    1_
$a Qin, Zhiqiang $u Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
700    1_
$a Morris, Gilbert F $u Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA $u Tulane Cancer Center, New Orleans, Louisiana, USA
700    1_
$a Li, Li $u Institute of Translational Research, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
700    1_
$a Lin, Zhen $u Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA zlin@tulane.edu $u Tulane Cancer Center, New Orleans, Louisiana, USA
773    0_
$w MED00003048 $t Journal of virology $x 1098-5514 $g Roč. 94, č. 22 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32847852 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507103354 $b ABA008
999    __
$a ok $b bmc $g 1650375 $s 1132362
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 94 $c 22 $e 20201027 $i 1098-5514 $m Journal of virology $n J Virol $x MED00003048
GRA    __
$a P20 GM121288 $p NIGMS NIH HHS $2 United States
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...